Xeris Biopharma Holdings, Inc. XERS Book value per share
Book value per share at other companies
Other financials
Where this comes from
Calculated from Xeris Biopharma Holdings, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s book value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s book value per share?
- Xeris Biopharma Holdings, Inc. (XERS) reported book value per share of $0.07 in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s book value per share changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s book value per share increased by 131.8% year-over-year, from -$0.23 to $0.07.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s book value per share?
- Over 5 years (2020 to 2025), Xeris Biopharma Holdings, Inc.'s book value per share has grown at a -36.9% compound annual growth rate (CAGR), from $0.79 to $0.08.
- What does book value per share mean?
- Shareholders' equity divided by diluted shares outstanding at the quarter end. The accounting (book) value attributable to each share.